Vasta Platform
VSTA
#7947
Rank
A$0.57 B
Marketcap
A$7.10
Share price
-1.60%
Change (1 day)
-7.21%
Change (1 year)
Categories

P/E ratio for Vasta Platform (VSTA)

P/E ratio as of November 2026 (TTM): -10.8

According to Vasta Platform's latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is -10.834. At the end of 2022 the company had a P/E ratio of -34.2.

P/E ratio history for Vasta Platform from 2020 to 2023

PE ratio at the end of each year

Year P/E ratio Change
2022-34.2125.32%
2021-15.2-90.22%
2020-155

P/E ratio for similar companies or competitors

Company P/E ratio P/E ratio differencediff. Country
Verastem Oncology
VSTM
-3.42-68.44%๐Ÿ‡บ๐Ÿ‡ธ USA
Spectrum Pharmaceuticals
SPPI
-2.86-73.59%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
-1.76-83.74%๐Ÿ‡บ๐Ÿ‡ธ USA

How to read a P/E ratio?

The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share. A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.

Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.
Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.